Inventor
WONG VERNON G
US51 patents
⚠️ This page may combine multiple inventors who share the name “WONG VERNON G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WONG VERNON G
12 patentsUS4521210AJun 4, 1985
Eye implant for relieving glaucoma, and device and method for use therewith
WONG VERNON G635 citations99
US8071120B2Dec 6, 2011
Methods for treating neovascularization and intravitreal implants
WONG VERNON G41 citations96
US8242099B2Aug 14, 2012
Implants and methods for treating inflammation-mediated conditions of the eye
WONG VERNON G27 citations95
US9011915B2Apr 21, 2015
Conveniently implantable sustained release drug compositions
WONG VERNON G21 citations93
US8722728B2May 13, 2014
Composition and method for treating dry eye syndrome
WONG VERNON G29 citations93
US8541413B2Sep 24, 2013
Sustained release eye drop formulations
WONG VERNON G25 citations93
US8088407B2Jan 3, 2012
Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
WONG VERNON G16 citations93
US8063031B2Nov 22, 2011
Implants and methods for treating inflammation-mediated conditions of the eye
WONG VERNON G15 citations92
US9289428B2Mar 22, 2016
Conveniently injectable or implantable sustained-release antioxidant formulations for therapies of ocular maladies or cancer
WONG VERNON G14 citations84
US8894578B2Nov 25, 2014
Implantable MEMs intraocular pressure sensor devices and methods for glaucoma monitoring
WONG VERNON G11 citations76
US9814773B2Nov 14, 2017
Sustained release formulations for delivery of proteins to the eye and methods of preparing same
WONG VERNON G5 citations73
US10022502B2Jul 17, 2018
Dose guides for injection syringe
WONG VERNON G4 citations72
ALLERGAN INC
11 patentsUS7033605B2Apr 25, 2006
Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
ALLERGAN INC68 citations99
US8043628B2Oct 25, 2011
Methods for reducing edema
ALLERGAN INC23 citations96
US7846468B2Dec 7, 2010
Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
ALLERGAN INC40 citations96
US7767223B2Aug 3, 2010
Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use
ALLERGAN INC27 citations96
US7625582B2Dec 1, 2009
Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
ALLERGAN INC36 citations96
US9012437B2Apr 21, 2015
Implants and methods for treating inflammation-mediated conditions of the eye
ALLERGAN INC11 citations92
US9592242B2Mar 14, 2017
Methods for treating edema in the eye and intraocular implants for use therefor
ALLERGAN INC4 citations84
US9283178B2Mar 15, 2016
Methods for treating edema in the eye and intraocular implants for use therefor
ALLERGAN INC6 citations84
US10206934B2Feb 19, 2019
Implants and methods for treating inflammation-mediated conditions of the eye
ALLERGAN INC1 citations72
US9775849B2Oct 3, 2017
Implants and methods for treating inflammation-mediated conditions of the eye
ALLERGAN INC2 citations72
US8828446B2Sep 9, 2014
Method for reducing transplant rejection in the eye and intraocular implants for use therefor
ALLERGAN INC1 citations63
OCULEX PHARM INC
6 patentsUS6699493B2Mar 2, 2004
Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
OCULEX PHARM INC345 citations99
US5824072AOct 20, 1998
Biocompatible ocular implants
OCULEX PHARM INC689 citations99
US5766242AJun 16, 1998
Biocompatible ocular implants
OCULEX PHARM INC696 citations99
US5443505AAug 22, 1995
Biocompatible ocular implants
OCULEX PHARM INC1,056 citations99
US6726918B1Apr 27, 2004
Methods for treating inflammation-mediated conditions of the eye
OCULEX PHARM INC331 citations98
US5632984AMay 27, 1997
Method of treatment of macular degeneration
OCULEX PHARM INC222 citations94
RAMSCOR INC
6 patentsUS7906136B2Mar 15, 2011
Conveniently implantable sustained release drug compositions
RAMSCOR INC131 citations98
US10744202B2Aug 18, 2020
Sustained release eye drop formulations
RAMSCOR INC8 citations84
US9993558B2Jun 12, 2018
Sustained release eye drop formulations
RAMSCOR INC5 citations84
US9737606B2Aug 22, 2017
Sustained release eye drop formulations
RAMSCOR INC5 citations84
US9474736B2Oct 25, 2016
Composition and method for treating dry eye syndrome
RAMSCOR INC7 citations84
US9144566B2Sep 29, 2015
Composition and method for treating dry eye syndrome
RAMSCOR INC7 citations84
Chibi Inc
5 patentsUS11234926B2Feb 1, 2022
Liquid depot for non-invasive sustained delivery of agents to the eye
Chibi Inc4 citations83
US12280141B2Apr 22, 2025
Liquid depot for non-invasive sustained delivery of agents to the eye
Chibi Inc1 citations74
US11497710B2Nov 15, 2022
Eye drop formulation and method for sustained delivery of medicament to the retina
Chibi Inc4 citations72
US12527738B2Jan 20, 2026
Liquid depot for non-invasive sustained delivery of agents to the eye
Chibi Inc0 citations62
US12472142B2Nov 18, 2025
Liquid depot for non-invasive sustained delivery of agents to the eye
Chibi Inc0 citations62
ICON BIOSCIENCE INC
4 patentsUS10799642B2Oct 13, 2020
Dose guides for injection syringe
ICON BIOSCIENCE INC4 citations71
US10159683B2Dec 25, 2018
Use of sustained release dexamethasone in post-cataract surgery inflammation
ICON BIOSCIENCE INC4 citations70
US9636347B2May 2, 2017
Sustained release formulations for the treatment of intraocular pressure or glaucoma
ICON BIOSCIENCE INC0 citations51
US9283231B2Mar 15, 2016
Sustained release formulations for the treatment of intraocular pressure of glaucoma
ICON BIOSCIENCE INC1 citations51
VISIONEX
3 patentsVISIONEX INC
1 patentOCULEX PHARMACETICALS INC
1 patentSEE CARE CORP
1 patentShowing the top 50 of 51 patents by PatentIndex Score.